Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept. - Wikidata - awgldk - TriplyDB

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

http://www.wikidata.org/entity/Q37999793

about

Liposomes as nanomedical devices Nanopharmacology in translational hematology and oncology Vincristine sulfate liposomal injection for acute lymphoblastic leukemia.The nanomaterial toolkit for neuroengineering.Liposomes and nanotechnology in drug development: focus on neurological targets.Nanomaterials for the Capture and Therapeutic Targeting of Circulating Tumor Cells.Itraconazole Niosomes Drug Delivery System and Its Antimycotic Activity against Candida albicans.Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer.Destination Known: Targeted Drug Delivery in Atherosclerosis and Thrombosis Preparation and Characterization of a Collagen-Liposome-Chondroitin Sulfate Matrix with Potential Application for Inflammatory Disorders Treatment

P2860

Q28088315-54E0979A-8AF3-4EA7-82E1-282523D1BA7C Q33961538-9C63EE6F-6712-4A11-85C3-50F64618265F Q37305758-B9A620C7-9F29-4939-86BA-1EBDF864030A Q37610362-75768F01-FFF9-43A6-82DD-0FE9350CFAED Q38088959-0B89431D-3920-4F2B-A7B8-69A928319261 Q42339249-90E106C9-83C6-40D9-8A4F-20730D6904C6 Q42429675-268FC6F7-F68E-4C71-AC98-D10336ADB9E6 Q55285429-C55CE96D-EC5F-46D6-8D3F-33862A1A77C7 Q57342839-A19E6D1D-F79F-4C8B-B796-DDD6B07D50F9 Q59059461-6A41AD33-331F-421A-94E7-C7B7C21F425C

P2860

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

http://www.wikidata.org/entity/Q37999793

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@en

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@nl

type

label

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@en

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@nl

prefLabel

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@en

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@nl

P1433

Q37999793-C8D7AB58-0A6D-4D6D-9A8B-A0265534ED96

P1476

Q37999793-12D07726-D1CE-4A2E-B51A-360E10E758A8

P2093

Q37999793-4842BBB0-B03C-4482-A11F-25BA201ED816

Q37999793-68B538CD-5041-4A2B-A87C-7B663DFAB576

Q37999793-C559A222-F5D4-4D49-99D6-70B0CA2BDECF

Q37999793-FBD09529-3B4D-4C5A-A4DD-FC8510B027EA

P2860

Q37999793-07B79003-8F41-44CB-9E15-C0191C34F035

Q37999793-093A85B4-97C2-47B8-884D-F1EAED063962

Q37999793-0A910A35-5E81-4BC1-B03D-E6C2C32A9F76

Q37999793-0B0E0449-7837-49DC-8E2F-1068CC0ABD8C

Q37999793-0EEC0AE4-3344-43E4-B1E5-675F6E9C32B5

Q37999793-0F27705E-E7F8-4178-8DE2-E34E0621069E

Q37999793-0F654D79-D964-413B-BD44-DE5EE1C2A36B

Q37999793-0F812343-A2C6-422F-ABE2-AB34B55BBB4A

Q37999793-10A9B7D5-1A87-4F3E-9426-6233558D0D7C

Q37999793-12433D8A-C3C0-4CF6-B45D-C8B0710F35F6

P304

Q37999793-C87A67CD-1287-49EA-BC1C-0EE612B3BA09

P31

Q37999793-E618E62C-60E7-4097-A60F-4B43AC0107FD

P356

Q37999793-41879DE0-3D2B-4C49-9749-49575835EAA9

P478

Q37999793-CDFD2A58-003B-4BF3-8B3E-A8AFBC54C909

P577

Q37999793-09B4B001-7BBF-4BC5-B2C1-5E1D917A7649

P5875

Q37999793-889B63A6-5788-4F18-A00F-0D922B12586D

P698

Q37999793-DDAF944E-7633-4C29-8A55-117F7C400845

P932

Q37999793-3EC03BC0-2636-4C78-BD2D-8299C53A5AB1

P356

P1433

ISRN pharmaceutics

P1476

Optimizing Druggability through Liposomal Formulations: New Approaches to an Old Concept.

@en

P2093

Athanassios Iliadis

http://www.w3.org/2001/XMLSchema#string

Dimitrios Bitounis

http://www.w3.org/2001/XMLSchema#string

Joseph Ciccolini

http://www.w3.org/2001/XMLSchema#string

Raphaelle Fanciullino

http://www.w3.org/2001/XMLSchema#string

P2860

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

Recent advances with liposomes as pharmaceutical carriers

Selective delivery of therapeutic agents for the diagnosis and treatment of cancer.

Liposomes targeted by fusion phage proteins

Novel peptide ligand directs liposomes toward EGF-R high-expressing cancer cells in vitro and in vivo.

Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors

Angiogenic vessel-targeting DDS by liposomalized oligopeptides.

Drug transport to brain with targeted liposomes

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence.

Overview of the lipid formulations of amphotericin B.

P304

738432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5402/2012/738432

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

223987062

http://www.w3.org/2001/XMLSchema#string

P698

22474607

http://www.w3.org/2001/XMLSchema#string

P932

3302123

http://www.w3.org/2001/XMLSchema#string